Regeneron Pharmaceuticals Inc. Stock Rises Monday, Outperforms Market

Americas Gold and Silver Corporation

Change company Symbol lookup

Select an option...

USAS Americas Gold and Silver Corporation

YELP Yelp Inc

CCLV Karbon-X Corp

NCBDF Bandai Namco Holdings Inc

GTN Gray Television Inc

BKD Brookdale Senior Living Inc

PMT PennyMac Mortgage Investment Trust

EVTVD Envirotech Vehicles Inc

AUTL Autolus Therapeutics PLC

CLRMW Clarim Acquisition Equity Warrant Exp 05 Jan 2026 *W EXP 01/05/2026

Materials : Metals & Mining | Small Cap Value
Based in Canada

Company profile

Americas Gold and Silver Corporation is a precious metals mining company in North America. The Company is engaged in acquisition, exploration, development and exploration of mineral resource properties in Mexico and the United States. The company is focused on three operating mines, including the San Rafael mine at its Cosala Operations in Mexico, the Galena Complex in Idaho, the United States and the Relief Canyon Mine in Nevada, the United States. The Cosala Operations are located in the state of Sinaloa, Mexico and consist of approximately 67 mining concessions that cover approximately 19,385 hectares. The Galena Complex is located in Idaho’s prolific Silver Valley, a district that is focused on producing silver, lead, zinc and copper from operations, such as the Bunker Hill, Sunshine and Lucky Friday mines. The Relief Canyon Mine is located in Pershing County, Nevada and the project encompasses an open pit mine and heap leach processing facility.

Regeneron Pharmaceuticals Inc. Stock Rises Monday, Outperforms Market

5:17 pm ET May 16, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Regeneron Pharmaceuticals Inc. (REGN) rallied 1.47% to $655.01 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.08% to 32,223.42 and the S&P 500 Index falling 0.39% to 4,008.01. This was the stock's third consecutive day of gains. Regeneron Pharmaceuticals Inc. closed $92.41 short of its 52-week high ($747.42), which the company reached on April 8th.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) rose 0.70% to $178.08, Novartis AG ADR (NOVN.EB) rose 2.32% to $87.81, and Amgen Inc. (AMGN) rose 1.00% to $243.87. Trading volume (486,890) remained 185,085 below its 50-day average volume of 671,975.

Data source: Dow Jones Market Data, FactSet. Data compiled May 16, 2022.

(END) Dow Jones Newswires

May 16, 2022 17:17 ET (21:17 GMT)